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GCM proteins constitute a small transcription factor family
with a DNA-binding domain exhibiting a novel fold com-
posed of two subdomains rigidly held together by coordi-
nation of one of two structural zinc cations. In all known
cases, GCM proteins exert the role of master regulators:
the prototypical family member determines gliogenesis in
 
Drosophila melanogaster
 
, whereas mammalian GCM pro-
teins orchestrate divergent aspects of development and
physiology in placenta, kidney, thymus, and parathyroid
gland. Recent data point to an involvement of GCM proteins
in different pathological contexts, such as preeclampsia,
hyper- or hypoparathyroidism, and parathyroid gland tumors.
 
The story of 
 
glial cells missing
 
 (
 
gcm
 
) started with a screen
for axonal pathfinding mutants in 
 
Drosophila melanogaster
 
(Hosoya et al., 1995; Jones et al., 1995; Vincent et al.,
1996). The identified prototypic GCM (also called Glide;
glial cell deficient) turned out to be the earliest binary switch
known to be necessary for glial cell development in the fruit
fly. Surplus of GCM/Glide instructs neural precursor cells
to differentiate into glial cells, whereas in the absence of
GCM/Glide neural precursors predominantly mature to
neurons. For details of GCM function in 
 
Drosophila
 
, we refer
the reader to several recent reviews (Jones, 2001; Van De Bor
and Giangrande, 2002). GCM proteins encode transcrip-
tion factors with a new type of zinc-containing DNA-bind-
ing domain, a so-called GCM domain, that recognizes the
DNA sequence 5
 
 
 
-ATGCGGGT-3
 
 
 
 or variations thereof
(Akiyama et al., 1996; Schreiber et al., 1997, 1998; Cohen
et al., 2002). The GCM domain represents the structural
hallmark and the only region of significant homology of the
different GCM family members. It is assembled from a large
and a small subdomain, both rich in 
 
 
 
-pleated sheets. One
of the two zinc cations tethers the two subdomains together,
while the other is located at the periphery of the small sub-
domain. A five-stranded 
 
 
 
-sheet from the large domain pro-
trudes into the major groove perpendicularly to the DNA
axis and thereby defines a novel use of 
 
 
 
-sheets in DNA rec-
ognition (Cohen et al., 2003).
All GCM proteins known to date are listed in Fig. 1. In
 
Drosophila
 
, a second 
 
gcm
 
 gene was identified (Kammerer
and Giangrande, 2001; Alfonso and Jones, 2002). This
 
gcm2/glide2
 
 gene is the result of a recent gene duplication
event and assists 
 
gcm/glide
 
 in its function during gliogenesis.
In the sea urchin 
 
Strongylocentrotus purpuratus
 
, SpGcm was
identified as a Notch-dependent factor (Calestani et al.,
2003). Interestingly, Notch signaling also accounts for 
 
gcm/
glide
 
 activation in 
 
Drosophila
 
’s nervous system, and thus
might be a common denominator in 
 
gcm
 
 regulation. A GCM
protein has also been identified and characterized in 
 
Gallus
gallus
 
 (Hashemolhosseini et al., 2004). Current sequencing
efforts have revealed additional GCM proteins in the ge-
nomes of 
 
Xenopus laevis
 
,
 
 Fugu rubripes
 
,
 
 
 
and 
 
Danio rerio
 
(unpublished data).
 
GCM in mammals
 
In search for regulators of mammalian gliogenesis, two
GCM proteins, named GCMa/Gcm1 and GCMb/Gcm2,
were identified (Akiyama et al., 1996; Kim et al., 1998;
Schreiber et al., 1998). No other functional 
 
gcm
 
 genes have
been detected in the human and mouse genome. Initially,
overexpression studies supported a function of mamma-
lian GCM proteins in nervous system development. Thus,
GCMa/Gcm1 disrupted neurogenesis or induced gliogenesis
when ectopically expressed in the nervous system of 
 
Drosophila
 
and mammals (Kim et al., 1998; Reifegerste et al., 1999;
Nait-Oumesmar et al., 2002; Iwasaki et al., 2003). How-
ever, all studies reported to date failed to detect significant
amounts of GCMa/Gcm1 or GCMb/Gcm2 in the mamma-
lian nervous system. If at all detected in embryonic brain,
expression rates were found orders of magnitude lower than
in other tissues. In GCMa/Gcm1 knockout mice that express
a 
 
 
 
-galactosidase marker instead of GCMa/Gcm1, no 
 
 
 
-galac-
tosidase–positive cells were detected in the brain (Hashe-
molhosseini et al., 2002).
Expression of mammalian GCM proteins was highest in
tissues other than the nervous system. During mouse devel-
opment from embryonic day (E) 7.5 to E17.5 GCMa/
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Gcm1 is expressed in the fetal part of the placenta and
defines a unique subset of trophoblast cells (Basyuk et
al., 1999). Knockout mouse models demonstrate embry-
onic lethality in the absence of GCMa/Gcm1 around E10
(Anson-Cartwright et al., 2000; Schreiber et al., 2000).
GCMa/Gcm1 plays a pivotal role in placental labyrinth de-
velopment where it is required for placental branching
morphogenesis. After 
 
GCMa/Gcm1
 
 deletion, the allantois is
still able to grow toward and contact the chorion, but sub-
sequent steps of placental labyrinth formation are affected
so that the failure to supply the embryo with sufficient
amounts of nutrients and oxygen leads to embryonic death.
Interestingly, the GCM protein identified from chicken is
also found in the egg’s chorion (Hashemolhosseini et al.,
2004). Thus, its localization is reminiscent of the spatial ex-
pression profile of GCMa/Gcm1. Apart from the fetal pla-
centa, GCMa/Gcm1 expression is selectively turned on at
late embryonic stages in the thymus and perinatally in the
kidney (Hashemolhosseini et al., 2002). In both of these
organs, GCMa/Gcm1 is expressed throughout adulthood.
In the thymic cortex a few clusters of 
 
 
 
30 GCMa/Gcm1-
positive cells appear first at E16.5. During development
and adult stages, the number of clusters increases with a
concomitant decrease of the number of cells to two to three
cells per cluster. In the kidney of mice, GCMa/Gcm1 ex-
pression was detected specifically in cells of the S3 segment
of proximal tubules. Because renal GCMa/Gcm1 expres-
sion occurs after kidney development is almost completed,
GCMa/Gcm1 is likely involved in kidney physiology.
Although not much is known about mechanistic aspects
of GCMa/Gcm1 function in the kidney, several aspects of
its regulation and function have been studied in the pla-
centa. Integrin-
 
 
 
4 was identified by antibody-blocking ex-
periments as an upstream component of the GCMa-signal-
ing cascade in placental trophoblasts (Stecca et al., 2002).
Once induced, GCM proteins must be able to efficiently
translocate to the nucleus to perform their function as tran-
scription factors. For that matter, all GCM proteins possess
nuclear localization signals. For some GCM proteins like
GCMb/Gcm2 or the prototypical GCM/Glide, these con-
form to the classical bipartite nuclear localization motif. In
others like GCMa/Gcm1 or chick GCM, nuclear localiza-
tion is mediated by regions without resemblance to known
nuclear localization signals (Hashemolhosseini et al., 2003).
Nuclear import was counteracted in GCMa/Gcm1 by an
amino terminal nuclear export activity. In fact, several GCM
proteins including GCMa/Gcm1 have also been found in
the cytosol (Bernardoni et al., 1999; Nait-Oumesmar et al.,
2000). Thus, nucleocytoplasmic shuttling might be a con-
served feature within this family of transcription factors and
might offer control of their activity either through sequestra-
tion or cytoplasmic posttranslational modification.
The transactivation capacity of all mammalian GCM pro-
teins can be attributed to two transactivation domains com-
pared with one in the prototypical 
 
Drosophila
 
 GCM/Glide
protein (Schreiber et al., 1998). Furthermore, GCM proteins
contain PEST motifs within their primary structure that
convey short half-lifes and low protein stability (Tuerk et al.,
2000) and influence target gene activation. For GCMa/
Gcm1, two placental target genes are known (Yamada et al.,
1999; Yu et al., 2002). These genes are human aromatase
and human syncytin. In the case of the aromatase gene,
GCMa/Gcm1 binds to a minimal enhancer, which is essen-
tial for placenta-specific transcription. In the case of syncy-
tin, GCMa/Gcm1 induces the promoter activity of the long-
terminal repeats of a syncytin-harboring retrovirus integrated
into the human genome and specifically drives endogenous
syncytin expression in human trophoblast lines. Syncytin in
humans can mediate fusion of cytotrophoblasts into the syn-
cytiotrophoblast layer, and syncytin expression is tightly reg-
ulated to maintain a functional syncytiotrophoblast layer.
However, mice do not possess a retrovirally encoded syn-
cytin, so that GCMa/Gcm1-dependent syncytin expression
cannot explain syncytiotrophoblast formation in mice. This
finding suggests additional placental GCMa/Gcm1-induc-
ible factors for labyrinth formation in the mouse.
Figure 1. Overview and domain topology of GCM proteins. Numbers to the right indicate amino acid residues in each GCM protein. To avoid 
superimposing multiple domains in the same GCM protein, one of the two is shown at half height. At the right, the expression site of each 
GCM protein is listed. Note the presence of two transactivation domains for mammalian and chick GCM proteins. For GCM2/Glide2, xeGCM, 
and SpGcm, the GCM domain is the only characterized domain. At the bottom, differently patterned squares corresponding to different functional 
domains are shown (DBD, DNA-binding domain; TA, transactivation domain; NLS, nuclear localization signal; NES, nuclear export signal; 
PEST, proline-glutamine-serine-threonine rich motif; ID, inhibitory domain). 
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GCMa/Gcm1 is likely to activate its target genes in com-
bination with interacting transcription factors. Recently,
Pitx2 has been identified as the first protein interacting with
GCMa/Gcm1 in placenta and kidney (unpublished data).
The expression of the second mammalian 
 
GCM
 
 gene,
GCMb/Gcm2, is restricted to parathyroid glands (Kim et al.,
1998). 30% of 
 
GCMb/Gcm2
 
-deficient mice die shortly after
birth owing to severe hypocalcaemia. The remaining were vi-
able, fertile, and had milder hypocalcaemia associated with
hyperphosphataemia and increased calcium elimination in
the urine without evidence of renal participation, altogether
features characteristic for hypoparathyroidism (Günther et
al., 2000). In agreement, 
 
GCMb/Gcm2
 
-deficient mice lack
parathyroid glands but show normal parathyroid hormone
serum levels. In the same study, GCMa/Gcm1-mediated
parathyroid hormone production in the thymus was uncov-
ered as an auxiliary regulatory mechanism for calcium ho-
meostasis in the absence of parathyroid glands.
In humans and mice, parathyroid glands as well as the
thymus arise from the pharyngeal pouches. GCMb/Gcm2
and Foxn1 are expressed in a complementary fashion in the
common primordium, thereby dividing it into separate do-
mains that prefigure parathyroid and thymus (Gordon et al.,
2001). Transcription factors that determine cell fate in the
common primordium and subsequent development of thy-
mus and parathyroid glands have recently been identified.
GCMb/Gcm2 expression is reduced in Pax1
 
 
 
/
 
 
 
 mutants by
E11.5, and further reduced or absent in Hoxa3
 
 
 
/
 
 
 
/Pax1
 
 
 
/
 
 
 
double mutants, indicating that GCMb/Gcm2 is under con-
trol of these transcription factors (Su et al., 2001).
 
GCM in disease
 
GCM proteins so far turned out to exert crucial roles as mas-
ter regulators in different developmental contexts. Therefore,
it would be surprising if they had no significance in patho-
logical circumstances. Concerning GCMa/Gcm1’s action in
the placenta, GCMa/Gcm1 is the first transcription factor
capable of initiating syncytiotrophoblast formation. Accord-
ingly, GCMa/Gcm1 might play a role in placental diseases
such as preeclampsia and intrauterine growth restriction.
These conditions complicate 5–10% of human pregnancies
and result in fetal to neonatal mortality and morbidity (An-
son-Cartwright et al., 2000). Indeed, decreased placental
GCMa/Gcm1 expression has been observed in preeclampsia
(Chen et al., 2004). GCMa/Gcm1 expression was reduced in
a statistically significant number of preeclamptic placentae
compared with gestational age-matched controls. In this work,
changes in the expression of syncytin were not analyzed. One
would assume that transcript levels of this GCMa/Gcm1 tar-
get gene are also diminished.
Because 
 
GCMb/Gcm2
 
 was identified as a master regula-
tory gene of parathyroid gland development, alterations of
its levels or activity might contribute to pathological states of
this organ. Homozygocity for a large intragenic deletion
within the 
 
GCMb/Gcm2
 
 gene was identified as the cause for
autosomal recessive hypoparathyroidism in a 5-wk-old pa-
tient suffering from generalized seizures (Ding et al., 2001).
Recently, another case of familial hypoparathyroidism has
been observed. In this case, a single amino acid change in the
GCM domain of GCMb/Gcm2 that results in a transcrip-
tionally significantly less active GCMb/Gcm2 was identified
as the underlying cause of the disease (unpublished data).
Thus, loss of GCMb/Gcm2 function might be a more com-
mon cause of hypoparathyroidism. Unexpectedly and con-
trary to mice, embryonic and adult thymus of healthy hu-
mans were assayed negative for both parathyroid hormone
and GCMa/Gcm1 (Maret et al., 2004).
Recent data also implicate GCMb/Gcm2 in tumorigene-
sis. These tumors are either located in the thymus or in the
parathyroid gland. Intrathymic adenomas have been re-
ported to secrete parathyroid hormone and produce GCMb/
Gcm2, suggesting that these tumors originate from mis-
placed parathyroid cells (Maret et al., 2004). GCMb/Gcm2
might be a diagnostic marker for these intrathymic ade-
nomas. The amount of GCMb/Gcm2 in cells of these in-
trathymic adenomas was not investigated. Human GCMb/
Gcm2 was also detected in several sporadic adenomas of the
parathyroid gland (Kanemura et al., 1999). In these para-
thyroid hormone-producing adenomas, GCMb/Gcm2 was
present, but expressed at significantly lower levels than in
surrounding normal parathyroid tissue arguing that there is
no strict correlation between GCMb/Gcm2 and parathyroid
hormone expression (Correa et al., 2002). It is tempting to
speculate that constant high levels of GCMb/Gcm2 expres-
sion are incompatible with proliferation and de-differentia-
tion in an adenoma.
 
Concluding remarks
 
Both mammalian GCM proteins play crucial roles at differ-
ent steps of development. GCMa/Gcm1 may have addi-
tional functions in renal physiology. It is a prime candidate
for a transcription factor that regulates expression of differ-
ent renal transporter genes. Due to the early embryonic le-
thality of a constitutive 
 
GCMa/Gcm1
 
 knockout mouse, this
has to be analyzed by generation and characterization of a
conditional knockout mouse. Apart from their normal func-
tion, mammalian GCM proteins have recently been impli-
cated in different human diseases such as preeclampsia,
hyper- or hypoparathyroidism, and tumorigenesis. Further
knowledge of the molecular action of mammalian GCM
proteins through identification of more complete sets of tar-
get genes and binding partners might clarify mechanistic de-
tails of their contribution to disease.
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